Piper Sandler & Co’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,217	Closed	-$61K	–	16
2018 Q1	$61K	Buy	+6,217	New	+$61K	0.12%	10